Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025. Yet, the international ...

In the closing of the recent trading day, Abbott (ABT) stood at $133.89, denoting a -1.47% move from the preceding trading day.

Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 1.3% over the past month.

The latest trading session saw Abbott (ABT) ending at $124.50, denoting a -2% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 3.46%. Meanwhile, the ...

Members of Congress have traded $ABT stock 13 times in the past 6 months. Of those trades, 6 have been purchases and 7 have been sales. Here’s a breakdown of recent ...

Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on August 11th, the Representative disclosed that they had sold between ...